Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection

NCT02102152 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT02102152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02102152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection
Lead sponsor
Rabin Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2014
Completion date
May 31, 2016
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiectasis with chronic infection with pseudomonas aeruginosa